PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Mazandaran University of Medical Sciences, Sari, Iran.\', \'Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.\', \'School of Public Health, Imperial College London, London, UK.\', \'Department of Emergency Medicine, Homerton University Hospital, London, UK.\', \'Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.\', \'Department of Medical Laboratory Sciences, School of Allied Medical Science, Mazandaran University of Medical Sciences, Sari, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/jac/dkaa501
?:hasPublicationType
?:journal
  • The Journal of antimicrobial chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33338232
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33338232>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33338232>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all